Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR

Journal of Human Hypertension volume 21, pages 154–158 (2007)Cite this article

Abstract

Our aim was to determine the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in hypertensive disorders during pregnancy. We conducted our experiments on isolated DNA samples of 73 healthy pregnant, 101 severe pre-eclamptic and 63 HELLP syndrome women in this study. The MTHFR C677T polymorphism was determined by quantitative real-time PCR method. A significantly higher number of the TT genotype (25.4%) was found in the HELLP syndrome group compared to the healthy (8.2%) and severe pre-eclamptics group (8.9%) (P=0.03). The frequency of the mutant T allele was found to be 45.2% of HELLP syndrome, whereas it was 32.2% of the healthy pregnant (P=0.03) and 30.2% (P=0.008) of the severe pre-eclamptic patients. In the HELLP group a high frequency of eclampsia was observed (12.6%) and among them 75% had the MTHFR C677T mutation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kupferminc MJ . Thrombophilia and pregnancy. Reprod Biol Endocrinol 2003; 1: 111–133.

    Article  Google Scholar 

  2. Kupferminc MJ . Thrombophilia and pre-eclampsia: the evidence so far. Clin Obstet Gynecol 2005; 48: 406–415.

    Article  Google Scholar 

  3. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Pals G, ten Kate LP, de Vries JI et al. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of pre-eclampsia. Am J Obstet Gynecol 2001; 184: 394–402.

    Article  CAS  Google Scholar 

  4. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrimsson R . Searching for pre-eclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105: 94–113.

    Article  CAS  Google Scholar 

  5. Nagy B, Rigo J, Fintor L, Romics L, Papp Z, Karadi I . Distribution of apolipoprotein(a) isoforms in normotensive and severe pre-eclamptic women. J Mat Fet Medicine 1999; 8: 270–274.

    Article  CAS  Google Scholar 

  6. Nagy B, Toth T, Rigo J, Karadi I, Romics L, Papp Z . Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women. Clin Genet 1998; 53: 478–491.

    Article  CAS  Google Scholar 

  7. Rigo Jr J, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I et al. Maternal and neonatal outcome of pre-eclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2001; 19: 163–172.

    Article  Google Scholar 

  8. Raijmakers MT, Zusterzeel PL, Steegers EA, Peters WH . Hyperhomocysteinaemia: a risk factor for pre-eclampsia? Eur J Obstet Gynecol 2001; 95: 226–228.

    Article  CAS  Google Scholar 

  9. Dekker GA, Sibai BM . Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obstet Gynecol 1998; 179: 1359–1375.

    Article  CAS  Google Scholar 

  10. Hubel CA . Dyslipidemia, iron, and oxidative stress in pre-eclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 1998; 16: 75–92.

    Article  CAS  Google Scholar 

  11. Ness RB, Roberts JM . Heterogeneous causes constituting the single syndrome of pre-eclampsia: hypothesis and its implications. Am J Obstet Gynecol 1996; 175: 1365–1370.

    Article  CAS  Google Scholar 

  12. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M et al. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis 2005; 19: 189–196.

    Article  CAS  Google Scholar 

  13. Goddijn-Wessel TA, Wouters MG, van de Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ et al. Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996; 66: 23–29.

    Article  CAS  Google Scholar 

  14. Greer IA . Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353: 1258–1265.

    Article  CAS  Google Scholar 

  15. McColl MD, Ellison J, Reid F, Tait RC, Walker ID, Greer IA . Prothrombin 20210 G → A, MTHFR C677T mutations in women with venous thromboembolism associated pregnancies. Br J Obstet Gynecol 2000; 107: 565–569.

    Article  CAS  Google Scholar 

  16. ACOG practice bulletin. Diagnosis and management of pre-eclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99: 159–167.

  17. Nagy B, Ban Z, Papp Z . The DNA isolation method has effect on allele drop-out and on the results of fluorescent PCR and DNA fragment analysis. Clin Chim Acta 2005; 360: 128–132.

    Article  CAS  Google Scholar 

  18. Aslanidis C, Schmitz G . High-speed methylenetetrahydrofolate reductase C → T 677 mutation detection on the LightCycler. In: Meuer S, Wittwer C, Nakagawara K-I (eds). Rapid Cycle Real-Time PCR. Methods and Applications: Springer, Berlin, 2001.

    Google Scholar 

  19. Lovricevic I, Franjic BD, Tomicic M, Vrkic N, De Syo D, Hudorovic N et al. 5,10-Methylenetetrahydrofolate reductase (MTHFR) 677 C → T genetic polymorphism in 228 Croatian volunteers. Coll Antropol 2004; 28: 647–654.

    CAS  PubMed  Google Scholar 

  20. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K . 677 C-T polymorphism of the methylenetetrahydrofolate reductase gene and pre-eclampsia. Obstet Gynecol 2000; 96: 277–280.

    CAS  PubMed  Google Scholar 

  21. O'Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH . Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian pre-eclampsia cohort. Hypertension 1999; 33: 1338–1341.

    Article  CAS  Google Scholar 

  22. Davalos IP, Moran MC, Martinez-Abundis E, Gonzalez-Ortiz M, Flores-Martinez SE, Machorro V et al. Methylenetetrahydrofolate reductase C677T polymorphism and Factor V Leiden variant in Mexican women with pre-eclampsia/eclampsia. Blood Cells Mol Dis 2005; 35 (1): 66–69.

    Article  CAS  Google Scholar 

  23. D'Elia AV, Driul L, Giacomello R, Colaone R, Fabbro D, Di Leonardo C et al. Frequency of factor V, prothrombin and methylenetatrahydrofolate reductase gene variants in pre-eclampsia. Gynecol Obstet Invest 2002; 53: 84–87.

    Article  Google Scholar 

  24. Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Pereaud PJ et al. Genetic susceptibility to pre-eclampsia: roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene cystathione β-synthase, and factor V Leiden. Am J Obstet Gynecol 2001; 184: 1211–1217.

    Article  CAS  Google Scholar 

  25. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P et al. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to pre-eclampsia. Thromb Haemost 1997; 77: 1052–1054.

    Article  CAS  Google Scholar 

  26. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T . Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997; 34: 525–526.

    Article  CAS  Google Scholar 

  27. Tranquilli AL, Giannubilo SR, Dell'Uomo B, Grandone E . Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors. Eur J Obstet Gynecol Reprod Biol 2004; 117: 144–147.

    Article  Google Scholar 

Download references

Acknowledgements

We are particularly grateful to Dr C Aslanidis (University of Regensburg, Germany) who provided the MTHFR C677T homo- and heterozygote control samples.

Author information

Authors and Affiliations

  1. 1st Department of Obstetrics and Gynaecology, Semmelweis University, Budapest, Hungary

    B Nagy, P Hupuczi & Z Papp

Authors
  1. B Nagy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Hupuczi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z Papp
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B Nagy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagy, B., Hupuczi, P. & Papp, Z. High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR. J Hum Hypertens 21, 154–158 (2007). https://doi.org/10.1038/sj.jhh.1002122

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002122

Keywords

This article is cited by

Search

Advanced search

Quick links